Fulgent Genetics, Inc. (FLGT)
Runs genetic testing labs and develops cancer drugs using DNA analysis.
$19.58-0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+5.7%
The outlook
FLGT is trading near the lower end of its 52-week range, positioned about 35% of the way up from its low. Analyst sentiment leans bearish, with the average price target sitting roughly 6% below the current price of $19.58. The stock shows mixed positioning relative to its moving averages, reflecting uncertain near-term momentum.
What’s behind the score
Price trendMixed vs its moving averages
52-week range35% of the way from its 52-week low to high
Price targetAvg target -6% vs current price
Analyst price target
~12-month · 2 analysts$18.50average target-5.5% vs now
Now $19.58
Low $15.00High $22.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$556.1M
52-wk high
$31.04
52-wk low
$13.46
50-day avg
$18.89
200-day avg
$21.45
Trailing P/E
—